Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

IMU Biosciences

IMU is a discovery engine mapping the immune system to advance precision medicine.
2021
11-50
London, England, United Kingdom
BiotechnologynologyHealth CareLife SciencePrecision Medicine

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

14.63M

Last Funding Amount

14.63M

Last Funding Date

24-01-2024

Startup Stage

Early Stage

Lead Investors

Life Extension Ventures, Molten Ventures, Beaumont Capital

Revenue

$1M to $10M

People

Founders